With a halt on new overtime rules, what’s next for startups?

November 29, 2016  |  Dan Schmidt

Photo by Crew

Disruption is good, right?

Well, as the Game of Thrones memes say: “Brace yourselves.”

The Department of Labor overtime rules that were originally scheduled to go into effect on Dec. 1 have now been indefinitely postponed due to an injunction issued on Nov.22 by U.S. District Judge Amos Mazzant.

These rules were set to nearly double the salary threshold for an employee to be considered “exempt” from overtime standards, and would have affected an estimated four million employees. The rules had the potential to significantly affect early-stage and pre-revenue companies that had elected to form as C-corporations, among other things.

The injunction was issued in response to a challenge filed by twenty-one states. The challenge is now working it’s way through the legal system, although the opinion of a majority of experts is that the ruling should now be considered to be effectively nullified long-term.

So, what are the next steps?

If you didn’t make any changes to your compensation packages, there’s now no need to change going forward. If your company has already issued notifications of salary increases, most experts are advising that these increases remain in effect for the time being. Thus, update your financials forecasts as needed, huddle up the team, and finish out the year strong.


Dan Schmidt is the founder and CEO of The Emerging Business CFO, a virtual business accounting and financial advisory firm that works to free founders and entrepreneurs from the stress of managing the daily operational grind. The company offers bookkeeping, accounting, cash flow management, payroll and CFO services.

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged ,
Featured Business
    Featured Founder

      2016 Startups to Watch

        stats here

        Related Posts on Startland News

        Harvesting KCMO’s urban-to-rural development wins means taking down silos, EDCKC leader says

        By Tommy Felts | September 11, 2025

        Editor’s note: The following is part of an ongoing feature series exploring impacts of initiatives within the Economic Development Corporation of Kansas City through a paid partnership with EDCKC. Kansas City’s growth isn’t just shaped by skyline-changing projects, said Heather Brown, describing a simple formula — and delicate balance — that keeps the region building upon its potential…

        KC-built AI command center helps businesses gain superpowers without losing their tech stack

        By Tommy Felts | September 9, 2025

        First envisioned as an AI-powered agent built to streamline operations at Kansas City-based Plexpod’s coworking spaces, Intuidy has evolved into its own operating system; one that is transforming the way companies operate, co-founder Grayson Smith said. Vantage — Intuidy’s flagship platform launched in early 2024 with the help of Smith’s brother, Gentry — is a…

        LISTEN: Biotech founder breaks down how she turns microorganisms into high-quality protein in just 24 hours

        By Tommy Felts | September 5, 2025

        On this episode of Startland News’ Plug and Play Topeka founder podcast series, we explore a ground-breaking food innovation with Katelijne “Kate” Bekers, co-founder and CEO of MicroHarvest. This biotech startup is pioneering the world’s fastest protein production — turning microorganisms into high-quality protein in just 24 hours, using sustainable fermentation and agricultural side-streams, while…

        LPOXY initiates $28M Series A financing with 5 Horizons Ventures to fund pivotal trial 

        By Tommy Felts | September 4, 2025

        PLATTE CITY, Mo. — Funding to secure the upcoming trial of a Missouri biopharmaceutical company’s solution for preventing a deadly gut infection could prove critical in the fight against a condition that claims 80 U.S. lives daily, said Dr. Larry Sutton. LPOXY Therapeutics, which is developing a novel non-antibiotic therapy to prevent Clostridioides difficile infections…